Pseudomonic acid D | CAS#85248-93-7 | antibiotic

MedKoo Cat#: 597942 | Name: Pseudomonic acid D

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Pseudomonic acid D is a topical antibiotic useful against superficial skin infections such as impetigo or folliculitis.

Chemical Structure

Pseudomonic acid D

CAS#85248-93-7

Theoretical Analysis

MedKoo Cat#: 597942

Name: Pseudomonic acid D

CAS#: 85248-93-7

Chemical Formula: C26H42O9

Exact Mass: 498.2829

Molecular Weight: 498.61

Elemental Analysis: C, 62.63; H, 8.49; O, 28.88

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

85248-93-7

Synonym

Pseudomonic acid D; Pseudomonic D;

IUPAC/Chemical Name

(E)-9-(((E)-4-((2S,3R,4R,5S)-3,4-dihydroxy-5-(((2S,3S)-3-((2S,3S)-3-hydroxybutan-2-yl)oxiran-2-yl)methyl)tetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoyl)oxy)non-4-enoic acid

InChi Key

RJGJFSVDQPCELW-VCXQKUNESA-N

InChi Code

InChI=1S/C26H42O9/c1-16(13-23(30)33-11-9-7-5-4-6-8-10-22(28)29)12-20-25(32)24(31)19(15-34-20)14-21-26(35-21)17(2)18(3)27/h4,6,13,17-21,24-27,31-32H,5,7-12,14-15H2,1-3H3,(H,28,29)/b6-4+,16-13+/t17-,18-,19-,20-,21-,24+,25-,26-/m0/s1

SMILES Code

O=C(O)CC/C=C/CCCCOC(/C=C(C)/C[C@H]1[C@H](O)[C@H](O)[C@@H](C[C@@H]2O[C@H]2[C@@H](C)[C@@H](O)C)CO1)=O

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.03.00

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 498.61 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Finnell SM, Rosenman MB, Christenson JC, Downs SM. Decolonization of children after incision and drainage for MRSA abscess: a retrospective cohort study. Clin Pediatr (Phila). 2015 May;54(5):445-50. doi: 10.1177/0009922814556059. Epub 2014 Nov 10. PubMed PMID: 25385929. 2: Parajuli P, Pandey RP, Pokhrel AR, Ghimire GP, Sohng JK. Enzymatic glycosylation of the topical antibiotic mupirocin. Glycoconj J. 2014 Nov;31(8):563-72. doi: 10.1007/s10719-014-9538-6. Epub 2014 Jul 30. PubMed PMID: 25069899. 3: Hetem DJ, Vogely HC, Severs TT, Troelstra A, Kusters JG, Bonten MJ. Acquisition of high-level mupirocin resistance in CoNS following nasal decolonization with mupirocin. J Antimicrob Chemother. 2015 Apr;70(4):1182-4. doi: 10.1093/jac/dku522. Epub 2014 Dec 23. PubMed PMID: 25538164. 4: Udawant SP, Chakraborty TK. Total synthesis of (+)-mupirocin H from D-glucose. J Org Chem. 2011 Aug 5;76(15):6331-7. doi: 10.1021/jo200396q. Epub 2011 Jul 8. PubMed PMID: 21707103. 5: Mehta MS, Hacek DM, Kufner BA, Price C, Peterson LR. Dose-ranging study to assess the application of intranasal 2% mupirocin calcium ointment to eradicate Staphylococcus aureus nasal colonization. Surg Infect (Larchmt). 2013 Feb;14(1):69-72. doi: 10.1089/sur.2012.086. Epub 2013 Feb 28. PubMed PMID: 23448592. 6: Hetem DJ, Bonten MJ. Clinical relevance of mupirocin resistance in Staphylococcus aureus. J Hosp Infect. 2013 Dec;85(4):249-56. doi: 10.1016/j.jhin.2013.09.006. Epub 2013 Sep 21. Review. PubMed PMID: 24144552. 7: Pérez-Roth E, Potel-Alvarellos C, Espartero X, Constela-Caramés L, Méndez-Álvarez S, Alvarez-Fernández M. Molecular epidemiology of plasmid-mediated high-level mupirocin resistance in methicillin-resistant Staphylococcus aureus in four Spanish health care settings. Int J Med Microbiol. 2013 May;303(4):201-4. doi: 10.1016/j.ijmm.2013.03.003. Epub 2013 Mar 29. PubMed PMID: 23611629. 8: Camus C, Salomon S, Bouchigny C, Gacouin A, Lavoué S, Donnio PY, Javaudin L, Chapplain JM, Uhel F, Le Tulzo Y, Bellissant E. Short-term decline in all-cause acquired infections with the routine use of a decontamination regimen combining topical polymyxin, tobramycin, and amphotericin B with mupirocin and chlorhexidine in the ICU: a single-center experience. Crit Care Med. 2014 May;42(5):1121-30. doi: 10.1097/CCM.0000000000000140. PubMed PMID: 24365857. 9: Jia MM, Li YS, Pei LJ, Liu M, Li XJ, Tang HB. [Effect of San-huang-sheng-fu oil on wounds of full-thickness scald in rabbits]. Zhonghua Shao Shang Za Zhi. 2013 Feb;29(1):50-4. Chinese. PubMed PMID: 23710723. 10: Shields JA, Rahman AS, Arthur CJ, Crosby J, Hothersall J, Simpson TJ, Thomas CM. Phosphopantetheinylation and specificity of acyl carrier proteins in the mupirocin biosynthetic cluster. Chembiochem. 2010 Jan 25;11(2):248-55. doi: 10.1002/cbic.200900565. PubMed PMID: 20013982. 11: Talon D, Marion C, Thouverez M, Bertrand X. Mupirocin resistance is not an inevitable consequence of mupirocin use. J Hosp Infect. 2011 Dec;79(4):366-7. doi: 10.1016/j.jhin.2011.08.009. Epub 2011 Oct 2. PubMed PMID: 21968283. 12: Bathoorn E, Hetem DJ, Alphenaar J, Kusters JG, Bonten MJ. Emergence of high-level mupirocin resistance in coagulase-negative staphylococci associated with increased short-term mupirocin use. J Clin Microbiol. 2012 Sep;50(9):2947-50. doi: 10.1128/JCM.00302-12. Epub 2012 Jul 3. PubMed PMID: 22760047; PubMed Central PMCID: PMC3421826. 13: Shiozawa H, Shimada A, Takahashi S. Thiomarinols D, E, F and G, new hybrid antimicrobial antibiotics produced by a marine bacterium; isolation, structure, and antimicrobial activity. J Antibiot (Tokyo). 1997 May;50(5):449-52. PubMed PMID: 9207918. 14: Chaturvedi P, Singh AK, Singh AK, Shukla S, Agarwal L. Prevalence of Mupirocin Resistant Staphylococcus aureus Isolates Among Patients Admitted to a Tertiary Care Hospital. N Am J Med Sci. 2014 Aug;6(8):403-7. doi: 10.4103/1947-2714.139293. PubMed PMID: 25210674; PubMed Central PMCID: PMC4158649. 15: Sit D, Kadiroglu AK, Kayabasi H, Yilmaz ME. Prophylactic intranasal mupirocin ointment in the treatment of peritonitis in continuous ambulatory peritoneal dialysis patients. Adv Ther. 2007 Mar-Apr;24(2):387-93. PubMed PMID: 17565930. 16: Agarwala S, Lad D, Agashe V, Sobti A. Prevalence of MRSA colonization in an adult urban Indian population undergoing orthopaedic surgery. J Clin Orthop Trauma. 2016 Jan-Mar;7(1):12-6. doi: 10.1016/j.jcot.2015.08.004. Epub 2015 Sep 11. PubMed PMID: 26908970; PubMed Central PMCID: PMC4735570. 17: Sesso R, Barbosa D, Leme IL, Sader H, Canziani ME, Manfredi S, Draibe S, Pignatari AC. Staphylococcus aureus prophylaxis in hemodialysis patients using central venous catheter: effect of mupirocin ointment. J Am Soc Nephrol. 1998 Jun;9(6):1085-92. PubMed PMID: 9621293. 18: Remm K, Koch K, Von Muffling T, Nowak B. Study on the microbial status of unseasoned ground turkey meat from an EU producer-a new product with risk potential? Br Poult Sci. 2009 Jul;50(4):495-503. doi: 10.1080/00071660903110877. PubMed PMID: 19735019. 19: Klochko VV, Zelena LB, Kim JY, Avdeeva LV, Reva ON. Prospects of a new antistaphylococcal drug batumin revealed by molecular docking and analysis of the complete genome sequence of the batumin-producer Pseudomonas batumici UCM B-321. Int J Antimicrob Agents. 2016 Jan;47(1):56-61. doi: 10.1016/j.ijantimicag.2015.10.006. Epub 2015 Oct 30. PubMed PMID: 26607338. 20: McCann M, Moore ZE. Interventions for preventing infectious complications in haemodialysis patients with central venous catheters. Cochrane Database Syst Rev. 2010 Jan 20;(1):CD006894. doi: 10.1002/14651858.CD006894.pub2. Review. PubMed PMID: 20091610.